<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">43302</article-id><article-id pub-id-type="doi">10.7554/eLife.43302</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group></article-categories><title-group><article-title>Cell-based HTS identifies a chemical chaperone for preventing ER protein aggregation and proteotoxicity</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-138967"><name><surname>Kitakaze</surname><given-names>Keisuke</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4852-1257</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125506"><name><surname>Taniuchi</surname><given-names>Shusuke</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125508"><name><surname>Kawano</surname><given-names>Eri</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125514"><name><surname>Hamada</surname><given-names>Yoshimasa</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125515"><name><surname>Miyake</surname><given-names>Masato</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125523"><name><surname>Oyadomari</surname><given-names>Miho</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125524"><name><surname>Kojima</surname><given-names>Hirotatsu</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125525"><name><surname>Kosako</surname><given-names>Hidetaka</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125520"><name><surname>Kuribara</surname><given-names>Tomoko</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125521"><name><surname>Yoshida</surname><given-names>Suguru</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5888-9330</contrib-id><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-125507"><name><surname>Hosoya</surname><given-names>Takamitsu</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-124121"><name><surname>Oyadomari</surname><given-names>Seiichi</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6766-1485</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Division of Molecular Biology, Institute for Genome Research, Institute of Advanced Medical Sciences</institution>, <institution>Tokushima University</institution>, <addr-line><named-content content-type="city">Tokushima</named-content></addr-line>, <country>Japan</country></aff><aff id="aff2"><institution content-type="dept">Drug Discovery Initiative (DDI)</institution>, <institution>The University of Tokyo</institution>, <addr-line><named-content content-type="city">Tokyo</named-content></addr-line>, <country>Japan</country></aff><aff id="aff3"><institution content-type="dept">Fujii Memorial Institute of Medical Sciences, Institute of Advanced Medical Sciences</institution>, <institution>Tokushima University</institution>, <addr-line><named-content content-type="city">Tokushima</named-content></addr-line>, <country>Japan</country></aff><aff id="aff4"><institution content-type="dept">Laboratory of Chemical Bioscience, Institute of Biomaterials and Bioengineering</institution>, <institution>Tokyo Medical and Dental University (TMDU)</institution>, <addr-line><named-content content-type="city">Tokyo</named-content></addr-line>, <country>Japan</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-88179"><name><surname>Shoulders</surname><given-names>Matthew D</given-names></name><role>Reviewing editor</role><aff><institution>Massachusetts Institute of Technology</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>oyadomar@tokushima-u.ac.jp</email> (SO);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>17</day><month>12</month><year>2019</year></pub-date><volume>8</volume><elocation-id>e43302</elocation-id><history><date date-type="received"><day>01</day><month>11</month><year>2018</year></date><date date-type="accepted"><day>24</day><month>11</month><year>2019</year></date></history><permissions><copyright-statement>Â© 2019, Kitakaze et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Kitakaze et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-43302-v1.pdf"/><abstract><p>The endoplasmic reticulum (ER) is responsible for folding secretory and membrane proteins, but disturbed ER proteostasis may lead to protein aggregation and subsequent cellular and clinical pathologies. Chemical chaperones have recently emerged as a potential therapeutic approach for ER stress-related diseases. Here, we identified 2-phenylimidazo[2,1-<italic>b</italic>]benzothiazole derivatives (IBTs) as chemical chaperones in a cell-based high-throughput screen. Biochemical and chemical biology approaches revealed that IBT21 directly binds to unfolded or misfolded proteins and inhibits protein aggregation. Finally, IBT21 prevented cell death caused by chemically induced ER stress and by a proteotoxin, an aggression-prone prion protein. Taken together, our data show the promise of IBTs as potent chemical chaperones that can ameliorate diseases resulting from protein aggregation under ER stress.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009619</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>JP18nk0101336</award-id><principal-award-recipient><name><surname>Oyadomari</surname><given-names>Seiichi</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100009619</institution-id><institution>Japan Agency for Medical Research and Development</institution></institution-wrap></funding-source><award-id>JP17am0101086</award-id><principal-award-recipient><name><surname>Kojima</surname><given-names>Hirotatsu</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Platform Project for Supporting Drug Discovery and Life Science Research, Basis for Supporting Innovative Drug Discovery and Life Science Research</institution></institution-wrap></funding-source><award-id>JP18am0101098</award-id><principal-award-recipient><name><surname>Hosoya</surname><given-names>Takamitsu</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution>a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology  of Japan</institution></institution-wrap></funding-source><award-id>16H05222</award-id><principal-award-recipient><name><surname>Oyadomari</surname><given-names>Seiichi</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><supplementary-material><ext-link xlink:href="elife-43302-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>